Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1094124

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1094124

Global Pharma 4.0 Market Insights, Forecast to 2028

PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Pharma 4.0 Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pharma 4.0 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Cloud
    • 1.2.3 On-premise
  • 1.3 Market by Application
    • 1.3.1 Global Pharma 4.0 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Pharmaceutical Industry
    • 1.3.3 IoT Industry
    • 1.3.4 Medical Equipment Industry
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharma 4.0 Market Perspective (2017-2028)
  • 2.2 Pharma 4.0 Growth Trends by Region
    • 2.2.1 Pharma 4.0 Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Pharma 4.0 Historic Market Size by Region (2017-2022)
    • 2.2.3 Pharma 4.0 Forecasted Market Size by Region (2023-2028)
  • 2.3 Pharma 4.0 Market Dynamics
    • 2.3.1 Pharma 4.0 Industry Trends
    • 2.3.2 Pharma 4.0 Market Drivers
    • 2.3.3 Pharma 4.0 Market Challenges
    • 2.3.4 Pharma 4.0 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Pharma 4.0 Players by Revenue
    • 3.1.1 Global Top Pharma 4.0 Players by Revenue (2017-2022)
    • 3.1.2 Global Pharma 4.0 Revenue Market Share by Players (2017-2022)
  • 3.2 Global Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Pharma 4.0 Revenue
  • 3.4 Global Pharma 4.0 Market Concentration Ratio
    • 3.4.1 Global Pharma 4.0 Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pharma 4.0 Revenue in 2021
  • 3.5 Pharma 4.0 Key Players Head office and Area Served
  • 3.6 Key Players Pharma 4.0 Product Solution and Service
  • 3.7 Date of Enter into Pharma 4.0 Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharma 4.0 Breakdown Data by Type

  • 4.1 Global Pharma 4.0 Historic Market Size by Type (2017-2022)
  • 4.2 Global Pharma 4.0 Forecasted Market Size by Type (2023-2028)

5 Pharma 4.0 Breakdown Data by Application

  • 5.1 Global Pharma 4.0 Historic Market Size by Application (2017-2022)
  • 5.2 Global Pharma 4.0 Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Pharma 4.0 Market Size (2017-2028)
  • 6.2 North America Pharma 4.0 Market Size by Type
    • 6.2.1 North America Pharma 4.0 Market Size by Type (2017-2022)
    • 6.2.2 North America Pharma 4.0 Market Size by Type (2023-2028)
    • 6.2.3 North America Pharma 4.0 Market Share by Type (2017-2028)
  • 6.3 North America Pharma 4.0 Market Size by Application
    • 6.3.1 North America Pharma 4.0 Market Size by Application (2017-2022)
    • 6.3.2 North America Pharma 4.0 Market Size by Application (2023-2028)
    • 6.3.3 North America Pharma 4.0 Market Share by Application (2017-2028)
  • 6.4 North America Pharma 4.0 Market Size by Country
    • 6.4.1 North America Pharma 4.0 Market Size by Country (2017-2022)
    • 6.4.2 North America Pharma 4.0 Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Pharma 4.0 Market Size (2017-2028)
  • 7.2 Europe Pharma 4.0 Market Size by Type
    • 7.2.1 Europe Pharma 4.0 Market Size by Type (2017-2022)
    • 7.2.2 Europe Pharma 4.0 Market Size by Type (2023-2028)
    • 7.2.3 Europe Pharma 4.0 Market Share by Type (2017-2028)
  • 7.3 Europe Pharma 4.0 Market Size by Application
    • 7.3.1 Europe Pharma 4.0 Market Size by Application (2017-2022)
    • 7.3.2 Europe Pharma 4.0 Market Size by Application (2023-2028)
    • 7.3.3 Europe Pharma 4.0 Market Share by Application (2017-2028)
  • 7.4 Europe Pharma 4.0 Market Size by Country
    • 7.4.1 Europe Pharma 4.0 Market Size by Country (2017-2022)
    • 7.4.2 Europe Pharma 4.0 Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharma 4.0 Market Size (2017-2028)
  • 8.2 Asia-Pacific Pharma 4.0 Market Size by Type
    • 8.2.1 Asia-Pacific Pharma 4.0 Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Pharma 4.0 Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Pharma 4.0 Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Pharma 4.0 Market Size by Application
    • 8.3.1 Asia-Pacific Pharma 4.0 Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Pharma 4.0 Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Pharma 4.0 Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Pharma 4.0 Market Size by Region
    • 8.4.1 Asia-Pacific Pharma 4.0 Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Pharma 4.0 Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Pharma 4.0 Market Size (2017-2028)
  • 9.2 Latin America Pharma 4.0 Market Size by Type
    • 9.2.1 Latin America Pharma 4.0 Market Size by Type (2017-2022)
    • 9.2.2 Latin America Pharma 4.0 Market Size by Type (2023-2028)
    • 9.2.3 Latin America Pharma 4.0 Market Share by Type (2017-2028)
  • 9.3 Latin America Pharma 4.0 Market Size by Application
    • 9.3.1 Latin America Pharma 4.0 Market Size by Application (2017-2022)
    • 9.3.2 Latin America Pharma 4.0 Market Size by Application (2023-2028)
    • 9.3.3 Latin America Pharma 4.0 Market Share by Application (2017-2028)
  • 9.4 Latin America Pharma 4.0 Market Size by Country
    • 9.4.1 Latin America Pharma 4.0 Market Size by Country (2017-2022)
    • 9.4.2 Latin America Pharma 4.0 Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharma 4.0 Market Size (2017-2028)
  • 10.2 Middle East & Africa Pharma 4.0 Market Size by Type
    • 10.2.1 Middle East & Africa Pharma 4.0 Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Pharma 4.0 Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Pharma 4.0 Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Pharma 4.0 Market Size by Application
    • 10.3.1 Middle East & Africa Pharma 4.0 Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Pharma 4.0 Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Pharma 4.0 Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Pharma 4.0 Market Size by Country
    • 10.4.1 Middle East & Africa Pharma 4.0 Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Pharma 4.0 Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Pfizer Inc
    • 11.1.1 Pfizer Inc Company Details
    • 11.1.2 Pfizer Inc Business Overview
    • 11.1.3 Pfizer Inc Pharma 4.0 Introduction
    • 11.1.4 Pfizer Inc Revenue in Pharma 4.0 Business (2017-2022)
    • 11.1.5 Pfizer Inc Recent Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Pharma 4.0 Introduction
    • 11.2.4 Abbott Laboratories Revenue in Pharma 4.0 Business (2017-2022)
    • 11.2.5 Abbott Laboratories Recent Developments
  • 11.3 GE Healthcare
    • 11.3.1 GE Healthcare Company Details
    • 11.3.2 GE Healthcare Business Overview
    • 11.3.3 GE Healthcare Pharma 4.0 Introduction
    • 11.3.4 GE Healthcare Revenue in Pharma 4.0 Business (2017-2022)
    • 11.3.5 GE Healthcare Recent Developments
  • 11.4 Boston Scientific
    • 11.4.1 Boston Scientific Company Details
    • 11.4.2 Boston Scientific Business Overview
    • 11.4.3 Boston Scientific Pharma 4.0 Introduction
    • 11.4.4 Boston Scientific Revenue in Pharma 4.0 Business (2017-2022)
    • 11.4.5 Boston Scientific Recent Developments
  • 11.5 Medtronic Plc.
    • 11.5.1 Medtronic Plc. Company Details
    • 11.5.2 Medtronic Plc. Business Overview
    • 11.5.3 Medtronic Plc. Pharma 4.0 Introduction
    • 11.5.4 Medtronic Plc. Revenue in Pharma 4.0 Business (2017-2022)
    • 11.5.5 Medtronic Plc. Recent Developments
  • 11.6 Lonza Group AG
    • 11.6.1 Lonza Group AG Company Details
    • 11.6.2 Lonza Group AG Business Overview
    • 11.6.3 Lonza Group AG Pharma 4.0 Introduction
    • 11.6.4 Lonza Group AG Revenue in Pharma 4.0 Business (2017-2022)
    • 11.6.5 Lonza Group AG Recent Developments
  • 11.7 GlaxoSmithKline plc.
    • 11.7.1 GlaxoSmithKline plc. Company Details
    • 11.7.2 GlaxoSmithKline plc. Business Overview
    • 11.7.3 GlaxoSmithKline plc. Pharma 4.0 Introduction
    • 11.7.4 GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2017-2022)
    • 11.7.5 GlaxoSmithKline plc. Recent Developments
  • 11.8 Koninklijke Philips N.V.
    • 11.8.1 Koninklijke Philips N.V. Company Details
    • 11.8.2 Koninklijke Philips N.V. Business Overview
    • 11.8.3 Koninklijke Philips N.V. Pharma 4.0 Introduction
    • 11.8.4 Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2017-2022)
    • 11.8.5 Koninklijke Philips N.V. Recent Developments
  • 11.9 Glatt GmbH
    • 11.9.1 Glatt GmbH Company Details
    • 11.9.2 Glatt GmbH Business Overview
    • 11.9.3 Glatt GmbH Pharma 4.0 Introduction
    • 11.9.4 Glatt GmbH Revenue in Pharma 4.0 Business (2017-2022)
    • 11.9.5 Glatt GmbH Recent Developments
  • 11.10 Vertex
    • 11.10.1 Vertex Company Details
    • 11.10.2 Vertex Business Overview
    • 11.10.3 Vertex Pharma 4.0 Introduction
    • 11.10.4 Vertex Revenue in Pharma 4.0 Business (2017-2022)
    • 11.10.5 Vertex Recent Developments
  • 11.11 Johnson & Johnson
    • 11.11.1 Johnson & Johnson Company Details
    • 11.11.2 Johnson & Johnson Business Overview
    • 11.11.3 Johnson & Johnson Pharma 4.0 Introduction
    • 11.11.4 Johnson & Johnson Revenue in Pharma 4.0 Business (2017-2022)
    • 11.11.5 Johnson & Johnson Recent Developments
  • 11.12 Goodly Innovations
    • 11.12.1 Goodly Innovations Company Details
    • 11.12.2 Goodly Innovations Business Overview
    • 11.12.3 Goodly Innovations Pharma 4.0 Introduction
    • 11.12.4 Goodly Innovations Revenue in Pharma 4.0 Business (2017-2022)
    • 11.12.5 Goodly Innovations Recent Developments
  • 11.13 QbDVision
    • 11.13.1 QbDVision Company Details
    • 11.13.2 QbDVision Business Overview
    • 11.13.3 QbDVision Pharma 4.0 Introduction
    • 11.13.4 QbDVision Revenue in Pharma 4.0 Business (2017-2022)
    • 11.13.5 QbDVision Recent Developments
  • 11.14 Electrosan
    • 11.14.1 Electrosan Company Details
    • 11.14.2 Electrosan Business Overview
    • 11.14.3 Electrosan Pharma 4.0 Introduction
    • 11.14.4 Electrosan Revenue in Pharma 4.0 Business (2017-2022)
    • 11.14.5 Electrosan Recent Developments
  • 11.15 GoSilico
    • 11.15.1 GoSilico Company Details
    • 11.15.2 GoSilico Business Overview
    • 11.15.3 GoSilico Pharma 4.0 Introduction
    • 11.15.4 GoSilico Revenue in Pharma 4.0 Business (2017-2022)
    • 11.15.5 GoSilico Recent Developments
  • 11.16 Smart Factory
    • 11.16.1 Smart Factory Company Details
    • 11.16.2 Smart Factory Business Overview
    • 11.16.3 Smart Factory Pharma 4.0 Introduction
    • 11.16.4 Smart Factory Revenue in Pharma 4.0 Business (2017-2022)
    • 11.16.5 Smart Factory Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pharma 4.0 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Cloud
    • 1.2.3 On-premise
  • 1.3 Market by Application
    • 1.3.1 Global Pharma 4.0 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Pharmaceutical Industry
    • 1.3.3 IoT Industry
    • 1.3.4 Medical Equipment Industry
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharma 4.0 Market Perspective (2017-2028)
  • 2.2 Pharma 4.0 Growth Trends by Region
    • 2.2.1 Pharma 4.0 Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Pharma 4.0 Historic Market Size by Region (2017-2022)
    • 2.2.3 Pharma 4.0 Forecasted Market Size by Region (2023-2028)
  • 2.3 Pharma 4.0 Market Dynamics
    • 2.3.1 Pharma 4.0 Industry Trends
    • 2.3.2 Pharma 4.0 Market Drivers
    • 2.3.3 Pharma 4.0 Market Challenges
    • 2.3.4 Pharma 4.0 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Pharma 4.0 Players by Revenue
    • 3.1.1 Global Top Pharma 4.0 Players by Revenue (2017-2022)
    • 3.1.2 Global Pharma 4.0 Revenue Market Share by Players (2017-2022)
  • 3.2 Global Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Pharma 4.0 Revenue
  • 3.4 Global Pharma 4.0 Market Concentration Ratio
    • 3.4.1 Global Pharma 4.0 Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pharma 4.0 Revenue in 2021
  • 3.5 Pharma 4.0 Key Players Head office and Area Served
  • 3.6 Key Players Pharma 4.0 Product Solution and Service
  • 3.7 Date of Enter into Pharma 4.0 Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharma 4.0 Breakdown Data by Type

  • 4.1 Global Pharma 4.0 Historic Market Size by Type (2017-2022)
  • 4.2 Global Pharma 4.0 Forecasted Market Size by Type (2023-2028)

5 Pharma 4.0 Breakdown Data by Application

  • 5.1 Global Pharma 4.0 Historic Market Size by Application (2017-2022)
  • 5.2 Global Pharma 4.0 Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Pharma 4.0 Market Size (2017-2028)
  • 6.2 North America Pharma 4.0 Market Size by Type
    • 6.2.1 North America Pharma 4.0 Market Size by Type (2017-2022)
    • 6.2.2 North America Pharma 4.0 Market Size by Type (2023-2028)
    • 6.2.3 North America Pharma 4.0 Market Share by Type (2017-2028)
  • 6.3 North America Pharma 4.0 Market Size by Application
    • 6.3.1 North America Pharma 4.0 Market Size by Application (2017-2022)
    • 6.3.2 North America Pharma 4.0 Market Size by Application (2023-2028)
    • 6.3.3 North America Pharma 4.0 Market Share by Application (2017-2028)
  • 6.4 North America Pharma 4.0 Market Size by Country
    • 6.4.1 North America Pharma 4.0 Market Size by Country (2017-2022)
    • 6.4.2 North America Pharma 4.0 Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Pharma 4.0 Market Size (2017-2028)
  • 7.2 Europe Pharma 4.0 Market Size by Type
    • 7.2.1 Europe Pharma 4.0 Market Size by Type (2017-2022)
    • 7.2.2 Europe Pharma 4.0 Market Size by Type (2023-2028)
    • 7.2.3 Europe Pharma 4.0 Market Share by Type (2017-2028)
  • 7.3 Europe Pharma 4.0 Market Size by Application
    • 7.3.1 Europe Pharma 4.0 Market Size by Application (2017-2022)
    • 7.3.2 Europe Pharma 4.0 Market Size by Application (2023-2028)
    • 7.3.3 Europe Pharma 4.0 Market Share by Application (2017-2028)
  • 7.4 Europe Pharma 4.0 Market Size by Country
    • 7.4.1 Europe Pharma 4.0 Market Size by Country (2017-2022)
    • 7.4.2 Europe Pharma 4.0 Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharma 4.0 Market Size (2017-2028)
  • 8.2 Asia-Pacific Pharma 4.0 Market Size by Type
    • 8.2.1 Asia-Pacific Pharma 4.0 Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Pharma 4.0 Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Pharma 4.0 Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Pharma 4.0 Market Size by Application
    • 8.3.1 Asia-Pacific Pharma 4.0 Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Pharma 4.0 Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Pharma 4.0 Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Pharma 4.0 Market Size by Region
    • 8.4.1 Asia-Pacific Pharma 4.0 Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Pharma 4.0 Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Pharma 4.0 Market Size (2017-2028)
  • 9.2 Latin America Pharma 4.0 Market Size by Type
    • 9.2.1 Latin America Pharma 4.0 Market Size by Type (2017-2022)
    • 9.2.2 Latin America Pharma 4.0 Market Size by Type (2023-2028)
    • 9.2.3 Latin America Pharma 4.0 Market Share by Type (2017-2028)
  • 9.3 Latin America Pharma 4.0 Market Size by Application
    • 9.3.1 Latin America Pharma 4.0 Market Size by Application (2017-2022)
    • 9.3.2 Latin America Pharma 4.0 Market Size by Application (2023-2028)
    • 9.3.3 Latin America Pharma 4.0 Market Share by Application (2017-2028)
  • 9.4 Latin America Pharma 4.0 Market Size by Country
    • 9.4.1 Latin America Pharma 4.0 Market Size by Country (2017-2022)
    • 9.4.2 Latin America Pharma 4.0 Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharma 4.0 Market Size (2017-2028)
  • 10.2 Middle East & Africa Pharma 4.0 Market Size by Type
    • 10.2.1 Middle East & Africa Pharma 4.0 Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Pharma 4.0 Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Pharma 4.0 Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Pharma 4.0 Market Size by Application
    • 10.3.1 Middle East & Africa Pharma 4.0 Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Pharma 4.0 Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Pharma 4.0 Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Pharma 4.0 Market Size by Country
    • 10.4.1 Middle East & Africa Pharma 4.0 Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Pharma 4.0 Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Pfizer Inc
    • 11.1.1 Pfizer Inc Company Details
    • 11.1.2 Pfizer Inc Business Overview
    • 11.1.3 Pfizer Inc Pharma 4.0 Introduction
    • 11.1.4 Pfizer Inc Revenue in Pharma 4.0 Business (2017-2022)
    • 11.1.5 Pfizer Inc Recent Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Pharma 4.0 Introduction
    • 11.2.4 Abbott Laboratories Revenue in Pharma 4.0 Business (2017-2022)
    • 11.2.5 Abbott Laboratories Recent Developments
  • 11.3 GE Healthcare
    • 11.3.1 GE Healthcare Company Details
    • 11.3.2 GE Healthcare Business Overview
    • 11.3.3 GE Healthcare Pharma 4.0 Introduction
    • 11.3.4 GE Healthcare Revenue in Pharma 4.0 Business (2017-2022)
    • 11.3.5 GE Healthcare Recent Developments
  • 11.4 Boston Scientific
    • 11.4.1 Boston Scientific Company Details
    • 11.4.2 Boston Scientific Business Overview
    • 11.4.3 Boston Scientific Pharma 4.0 Introduction
    • 11.4.4 Boston Scientific Revenue in Pharma 4.0 Business (2017-2022)
    • 11.4.5 Boston Scientific Recent Developments
  • 11.5 Medtronic Plc.
    • 11.5.1 Medtronic Plc. Company Details
    • 11.5.2 Medtronic Plc. Business Overview
    • 11.5.3 Medtronic Plc. Pharma 4.0 Introduction
    • 11.5.4 Medtronic Plc. Revenue in Pharma 4.0 Business (2017-2022)
    • 11.5.5 Medtronic Plc. Recent Developments
  • 11.6 Lonza Group AG
    • 11.6.1 Lonza Group AG Company Details
    • 11.6.2 Lonza Group AG Business Overview
    • 11.6.3 Lonza Group AG Pharma 4.0 Introduction
    • 11.6.4 Lonza Group AG Revenue in Pharma 4.0 Business (2017-2022)
    • 11.6.5 Lonza Group AG Recent Developments
  • 11.7 GlaxoSmithKline plc.
    • 11.7.1 GlaxoSmithKline plc. Company Details
    • 11.7.2 GlaxoSmithKline plc. Business Overview
    • 11.7.3 GlaxoSmithKline plc. Pharma 4.0 Introduction
    • 11.7.4 GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2017-2022)
    • 11.7.5 GlaxoSmithKline plc. Recent Developments
  • 11.8 Koninklijke Philips N.V.
    • 11.8.1 Koninklijke Philips N.V. Company Details
    • 11.8.2 Koninklijke Philips N.V. Business Overview
    • 11.8.3 Koninklijke Philips N.V. Pharma 4.0 Introduction
    • 11.8.4 Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2017-2022)
    • 11.8.5 Koninklijke Philips N.V. Recent Developments
  • 11.9 Glatt GmbH
    • 11.9.1 Glatt GmbH Company Details
    • 11.9.2 Glatt GmbH Business Overview
    • 11.9.3 Glatt GmbH Pharma 4.0 Introduction
    • 11.9.4 Glatt GmbH Revenue in Pharma 4.0 Business (2017-2022)
    • 11.9.5 Glatt GmbH Recent Developments
  • 11.10 Vertex
    • 11.10.1 Vertex Company Details
    • 11.10.2 Vertex Business Overview
    • 11.10.3 Vertex Pharma 4.0 Introduction
    • 11.10.4 Vertex Revenue in Pharma 4.0 Business (2017-2022)
    • 11.10.5 Vertex Recent Developments
  • 11.11 Johnson & Johnson
    • 11.11.1 Johnson & Johnson Company Details
    • 11.11.2 Johnson & Johnson Business Overview
    • 11.11.3 Johnson & Johnson Pharma 4.0 Introduction
    • 11.11.4 Johnson & Johnson Revenue in Pharma 4.0 Business (2017-2022)
    • 11.11.5 Johnson & Johnson Recent Developments
  • 11.12 Goodly Innovations
    • 11.12.1 Goodly Innovations Company Details
    • 11.12.2 Goodly Innovations Business Overview
    • 11.12.3 Goodly Innovations Pharma 4.0 Introduction
    • 11.12.4 Goodly Innovations Revenue in Pharma 4.0 Business (2017-2022)
    • 11.12.5 Goodly Innovations Recent Developments
  • 11.13 QbDVision
    • 11.13.1 QbDVision Company Details
    • 11.13.2 QbDVision Business Overview
    • 11.13.3 QbDVision Pharma 4.0 Introduction
    • 11.13.4 QbDVision Revenue in Pharma 4.0 Business (2017-2022)
    • 11.13.5 QbDVision Recent Developments
  • 11.14 Electrosan
    • 11.14.1 Electrosan Company Details
    • 11.14.2 Electrosan Business Overview
    • 11.14.3 Electrosan Pharma 4.0 Introduction
    • 11.14.4 Electrosan Revenue in Pharma 4.0 Business (2017-2022)
    • 11.14.5 Electrosan Recent Developments
  • 11.15 GoSilico
    • 11.15.1 GoSilico Company Details
    • 11.15.2 GoSilico Business Overview
    • 11.15.3 GoSilico Pharma 4.0 Introduction
    • 11.15.4 GoSilico Revenue in Pharma 4.0 Business (2017-2022)
    • 11.15.5 GoSilico Recent Developments
  • 11.16 Smart Factory
    • 11.16.1 Smart Factory Company Details
    • 11.16.2 Smart Factory Business Overview
    • 11.16.3 Smart Factory Pharma 4.0 Introduction
    • 11.16.4 Smart Factory Revenue in Pharma 4.0 Business (2017-2022)
    • 11.16.5 Smart Factory Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

List of Tables

  • Table 1. Global Pharma 4.0 Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Cloud
  • Table 3. Key Players of On-premise
  • Table 4. Global Pharma 4.0 Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Pharma 4.0 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Pharma 4.0 Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Pharma 4.0 Market Share by Region (2017-2022)
  • Table 8. Global Pharma 4.0 Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Pharma 4.0 Market Share by Region (2023-2028)
  • Table 10. Pharma 4.0 Market Trends
  • Table 11. Pharma 4.0 Market Drivers
  • Table 12. Pharma 4.0 Market Challenges
  • Table 13. Pharma 4.0 Market Restraints
  • Table 14. Global Pharma 4.0 Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Pharma 4.0 Revenue Share by Players (2017-2022)
  • Table 16. Global Top Pharma 4.0 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2021)
  • Table 17. Ranking of Global Top Pharma 4.0 Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Pharma 4.0 Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Pharma 4.0 Product Solution and Service
  • Table 21. Date of Enter into Pharma 4.0 Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Pharma 4.0 Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Pharma 4.0 Revenue Market Share by Type (2017-2022)
  • Table 25. Global Pharma 4.0 Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Pharma 4.0 Revenue Market Share by Type (2023-2028)
  • Table 27. Global Pharma 4.0 Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Pharma 4.0 Revenue Share by Application (2017-2022)
  • Table 29. Global Pharma 4.0 Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Pharma 4.0 Revenue Share by Application (2023-2028)
  • Table 31. North America Pharma 4.0 Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Pharma 4.0 Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Pharma 4.0 Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Pharma 4.0 Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Pharma 4.0 Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Pharma 4.0 Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Pharma 4.0 Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Pharma 4.0 Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Pharma 4.0 Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Pharma 4.0 Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Pharma 4.0 Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Pharma 4.0 Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Pharma 4.0 Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Pharma 4.0 Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Pharma 4.0 Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Pharma 4.0 Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Pharma 4.0 Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Pharma 4.0 Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Pharma 4.0 Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Pharma 4.0 Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Pharma 4.0 Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Pharma 4.0 Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Pfizer Inc Company Details
  • Table 62. Pfizer Inc Business Overview
  • Table 63. Pfizer Inc Pharma 4.0 Product
  • Table 64. Pfizer Inc Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 65. Pfizer Inc Recent Developments
  • Table 66. Abbott Laboratories Company Details
  • Table 67. Abbott Laboratories Business Overview
  • Table 68. Abbott Laboratories Pharma 4.0 Product
  • Table 69. Abbott Laboratories Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 70. Abbott Laboratories Recent Developments
  • Table 71. GE Healthcare Company Details
  • Table 72. GE Healthcare Business Overview
  • Table 73. GE Healthcare Pharma 4.0 Product
  • Table 74. GE Healthcare Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 75. GE Healthcare Recent Developments
  • Table 76. Boston Scientific Company Details
  • Table 77. Boston Scientific Business Overview
  • Table 78. Boston Scientific Pharma 4.0 Product
  • Table 79. Boston Scientific Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 80. Boston Scientific Recent Developments
  • Table 81. Medtronic Plc. Company Details
  • Table 82. Medtronic Plc. Business Overview
  • Table 83. Medtronic Plc. Pharma 4.0 Product
  • Table 84. Medtronic Plc. Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 85. Medtronic Plc. Recent Developments
  • Table 86. Lonza Group AG Company Details
  • Table 87. Lonza Group AG Business Overview
  • Table 88. Lonza Group AG Pharma 4.0 Product
  • Table 89. Lonza Group AG Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 90. Lonza Group AG Recent Developments
  • Table 91. GlaxoSmithKline plc. Company Details
  • Table 92. GlaxoSmithKline plc. Business Overview
  • Table 93. GlaxoSmithKline plc. Pharma 4.0 Product
  • Table 94. GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 95. GlaxoSmithKline plc. Recent Developments
  • Table 96. Koninklijke Philips N.V. Company Details
  • Table 97. Koninklijke Philips N.V. Business Overview
  • Table 98. Koninklijke Philips N.V. Pharma 4.0 Product
  • Table 99. Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 100. Koninklijke Philips N.V. Recent Developments
  • Table 101. Glatt GmbH Company Details
  • Table 102. Glatt GmbH Business Overview
  • Table 103. Glatt GmbH Pharma 4.0 Product
  • Table 104. Glatt GmbH Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 105. Glatt GmbH Recent Developments
  • Table 106. Vertex Company Details
  • Table 107. Vertex Business Overview
  • Table 108. Vertex Pharma 4.0 Product
  • Table 109. Vertex Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 110. Vertex Recent Developments
  • Table 111. Johnson & Johnson Company Details
  • Table 112. Johnson & Johnson Business Overview
  • Table 113. Johnson & Johnson Pharma 4.0 Product
  • Table 114. Johnson & Johnson Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 115. Johnson & Johnson Recent Developments
  • Table 116. Goodly Innovations Company Details
  • Table 117. Goodly Innovations Business Overview
  • Table 118. Goodly Innovations Pharma 4.0 Product
  • Table 119. Goodly Innovations Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 120. Goodly Innovations Recent Developments
  • Table 121. QbDVision Company Details
  • Table 122. QbDVision Business Overview
  • Table 123. QbDVision Pharma 4.0 Product
  • Table 124. QbDVision Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 125. QbDVision Recent Developments
  • Table 126. Electrosan Company Details
  • Table 127. Electrosan Business Overview
  • Table 128. Electrosan Pharma 4.0 Product
  • Table 129. Electrosan Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 130. Electrosan Recent Developments
  • Table 131. GoSilico Company Details
  • Table 132. GoSilico Business Overview
  • Table 133. GoSilico Pharma 4.0 Product
  • Table 134. GoSilico Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 135. GoSilico Recent Developments
  • Table 136. Smart Factory Company Details
  • Table 137. Smart Factory Business Overview
  • Table 138. Smart Factory Pharma 4.0 Product
  • Table 139. Smart Factory Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
  • Table 140. Smart Factory Recent Developments
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Pharma 4.0 Market Share by Type: 2021 VS 2028
  • Figure 2. Cloud Features
  • Figure 3. On-premise Features
  • Figure 4. Global Pharma 4.0 Market Share by Application: 2021 VS 2028
  • Figure 5. Pharmaceutical Industry Case Studies
  • Figure 6. IoT Industry Case Studies
  • Figure 7. Medical Equipment Industry Case Studies
  • Figure 8. Others Case Studies
  • Figure 9. Pharma 4.0 Report Years Considered
  • Figure 10. Global Pharma 4.0 Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Pharma 4.0 Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Pharma 4.0 Market Share by Region: 2021 VS 2028
  • Figure 13. Global Pharma 4.0 Market Share by Players in 2021
  • Figure 14. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Pharma 4.0 Revenue in 2021
  • Figure 16. North America Pharma 4.0 Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Pharma 4.0 Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Pharma 4.0 Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Pharma 4.0 Market Size Share by Country (2017-2028)
  • Figure 20. United States Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Pharma 4.0 Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Pharma 4.0 Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Pharma 4.0 Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Pharma 4.0 Market Size Share by Country (2017-2028)
  • Figure 26. Germany Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Pharma 4.0 Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Pharma 4.0 Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Pharma 4.0 Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Pharma 4.0 Market Size Share by Region (2017-2028)
  • Figure 36. China Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 42. Latin America Pharma 4.0 Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Pharma 4.0 Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Pharma 4.0 Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Pharma 4.0 Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Pharma 4.0 Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Pharma 4.0 Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Pharma 4.0 Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Pharma 4.0 Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Pfizer Inc Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 56. Abbott Laboratories Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 57. GE Healthcare Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 58. Boston Scientific Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 59. Medtronic Plc. Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 60. Lonza Group AG Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 61. GlaxoSmithKline plc. Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 62. Koninklijke Philips N.V. Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 63. Glatt GmbH Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 64. Vertex Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 65. Johnson & Johnson Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 66. Goodly Innovations Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 67. QbDVision Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 68. Electrosan Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 69. GoSilico Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 70. Smart Factory Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
  • Figure 71. Bottom-up and Top-down Approaches for This Report
  • Figure 72. Data Triangulation
  • Figure 73. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!